IL10 and cancer: Our analysis demonstrated that IL-6, IL-8, IL-10, and TNFα are promising novel candidate markers for the detection of pancreatic adenocarcinoma, whereas IL-23 might be valuable for its ability to exclude a diagnosis of cancer.